Latest Breaking News On - Skin clearance rates - Page 1 : comparemela.com

Expert dermatologists highlight the benefits of head-to-head trials for various agents for the management of plaque psoriasis and review the top-line results of a study comparing risankizumab and apremilast.

Benjamin lockshinSandy blauveltBruce stroberJennifer soungPlaque psoriasisHead to studiesSkin clearance ratesIl 23 inhibitorsMeta analysisAcumulative effect